Carsten Krueger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carsten Krueger has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Joan Louise Robinson
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada
2 shared publications - Alexander Hansen
Department of Cardiology, University of Heidelberg, Germany
1 shared publication - Alison A Lopez
Department of Paediatrics, London Health Sciences Centre , London, Ontario
1 shared publication - Amandine Bemmo
Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Canada
1 shared publication Andrew Calzavara
ICES , Toronto, Ontario
1 shared publicationAnne Tsampalieros
Children’s Hospital of Eastern Ontario Research Institute
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e254
Does a mobile application lend a hand for promoting antimicrobial stewardship? A survey of users
Analytics of antimicrobial stewardship applications (ASApp) from two pediatric hospitals over 24 months revealed an average of 4922 monthly sessions. A survey of users reported use in all clinical areas with 30% exclusively in outpatient settings. Overall, >70% reported using the recommendations and almost all self-reported an impact on practice.
- 3 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e254
Open AccessDoes a mobile application lend a hand for promoting antimicrobial stewardship? A survey of users
Analytics of antimicrobial stewardship applications (ASApp) from two pediatric hospitals over 24 months revealed an average of 4922 monthly sessions. A survey of users reported use in all clinical areas with 30% exclusively in outpatient settings. Overall, >70% reported using the recommendations and almost all self-reported an impact on practice.
- Open Access
- 19 March 2026
- Published by Springer Nature in Canadian Journal of Public Health
- Vol. 117 (4) , 1-12
Prenatal characteristics and factors contributing to congenital syphilis: A descriptive analysis of cases reported to the Canadian Paediatric Surveillance Program June 2021 through May 2023
Objectives: The incidence of congenital syphilis (CS) in Canada increased from 2.1 to 14.5 reported confirmed cases/100,000 live births from 2017 to 2023 (from 8 to 53 cases). We aimed to document prenatal characteristics and contributing factors to CS among mothers or birthing parents (M/BP) of infants with CS in Canada. Methods: Participants of the Canadian Paediatric Surveillance Program, which includes both paediatricians and paediatric subspecialists, were invited to report on CS cases meeting the study case definition between June 2021 and May 2023. A detailed questionnaire was completed by the reporting clinician. We used descriptive statistics in the assessment of prenatal risk factors among cases, including data on healthcare access, diagnosis, and treatment as well as on socio-demographic, socio-economic and socio-behavioural determinants. Results: During the 24-month study period, 245 live-born cases of CS were reported, including 81 (33.1%) confirmed and 164 (66.9%) probable cases from seven provinces and territories. Substance use in pregnancy was reported in 65% of cases. Only half of M/BP had at least 1 prenatal care visit during their pregnancy, while only one-quarter had ≥ 1 prenatal care visit in each trimester. In a quarter of cases, no syphilis screening was performed during pregnancy. Prenatal syphilis treatment was not initiated among 20% who screened positive. Conclusion: In this country-wide assessment, we identified substantial failures in the delivery of adequate prenatal care to M/BP of live-born infants diagnosed with CS. Public health action, such as community outreach to ensure prenatal care for all pregnant people, with specific attention to the prenatal healthcare needs and engagement in the care of those who use substances, is pressing.
- 19 March 2026
- Published by Springer Nature in Canadian Journal of Public Health
- Vol. 117 (4) , 1-12
Open AccessPrenatal characteristics and factors contributing to congenital syphilis: A descriptive analysis of cases reported to the Canadian Paediatric Surveillance Program June 2021 through May 2023
Objectives: The incidence of congenital syphilis (CS) in Canada increased from 2.1 to 14.5 reported confirmed cases/100,000 live births from 2017 to 2023 (from 8 to 53 cases). We aimed to document prenatal characteristics and contributing factors to CS among mothers or birthing parents (M/BP) of infants with CS in Canada. Methods: Participants of the Canadian Paediatric Surveillance Program, which includes both paediatricians and paediatric subspecialists, were invited to report on CS cases meeting the study case definition between June 2021 and May 2023. A detailed questionnaire was completed by the reporting clinician. We used descriptive statistics in the assessment of prenatal risk factors among cases, including data on healthcare access, diagnosis, and treatment as well as on socio-demographic, socio-economic and socio-behavioural determinants. Results: During the 24-month study period, 245 live-born cases of CS were reported, including 81 (33.1%) confirmed and 164 (66.9%) probable cases from seven provinces and territories. Substance use in pregnancy was reported in 65% of cases. Only half of M/BP had at least 1 prenatal care visit during their pregnancy, while only one-quarter had ≥ 1 prenatal care visit in each trimester. In a quarter of cases, no syphilis screening was performed during pregnancy. Prenatal syphilis treatment was not initiated among 20% who screened positive. Conclusion: In this country-wide assessment, we identified substantial failures in the delivery of adequate prenatal care to M/BP of live-born infants diagnosed with CS. Public health action, such as community outreach to ensure prenatal care for all pregnant people, with specific attention to the prenatal healthcare needs and engagement in the care of those who use substances, is pressing.
- Open Access
- 29 January 2026
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 31 (3) , 221-227
Management of serious Staphylococcus aureus infections in children: A survey of paediatric infectious diseases physicians in Canada
Objectives: Staphylococcus aureus (SA) infections are a common problem in children and a frequent reason for paediatric infectious diseases (PID) consultation. We sought to describe contemporary practices of Canadian PID physicians for management of serious paediatric SA infections. Methods: We developed and disseminated a national, self-administered, cross-sectional online survey of Canadian PID consultants to assess practice patterns involving the management of serious paediatric SA infections. Results: Thirty-nine of 84 (46%) PID consultants across 14 Canadian children's hospitals completed the survey; 48.7% (n = 19) had been practising for 10 or more years and 92.1% (n = 35) completed their PID training in Canada. For methicillin sensitive SA (MSSA) infections outside the central nervous system, 56.4% (n = 22) of respondents preferred cefazolin. Ceftriaxone/cefotaxime was used as definitive treatment for MSSA by 26.3% (n = 10). Prescribing penicillin for penicillin sensitive SA was divided with 51.3% (n = 20) choosing to use it. Most respondents chose to treat SA bacteremia (SAB) with no focus in immunocompetent children and neonates for 14 days, 89.7% (n = 35) and 92.3% (n = 36), respectively. Variability was observed in the practices of ordering abdominal ultrasounds and echocardiograms for SAB with no focus, and in the transition to oral antibiotics for MSSA bacteremia. Variability was also noted in treating osteoarticular infections with methicillin resistant SA bacteremia, with 56.4% (n = 22) choosing intravenous antibiotics until an appropriate clinical response is observed while others advised a minimum 7 (17.9%, n = 7) or 14 (12.8%, n = 5) day intravenous course. Conclusion: Our study highlights both areas of consistency and variability among Canadian PID physicians in managing serious SA infections in children, emphasizing the need for evidence-based paediatric guidelines and increased inclusion of children in clinical trials.
- 29 January 2026
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 31 (3) , 221-227
Open AccessManagement of serious Staphylococcus aureus infections in children: A survey of paediatric infectious diseases physicians in Canada
Objectives: Staphylococcus aureus (SA) infections are a common problem in children and a frequent reason for paediatric infectious diseases (PID) consultation. We sought to describe contemporary practices of Canadian PID physicians for management of serious paediatric SA infections. Methods: We developed and disseminated a national, self-administered, cross-sectional online survey of Canadian PID consultants to assess practice patterns involving the management of serious paediatric SA infections. Results: Thirty-nine of 84 (46%) PID consultants across 14 Canadian children's hospitals completed the survey; 48.7% (n = 19) had been practising for 10 or more years and 92.1% (n = 35) completed their PID training in Canada. For methicillin sensitive SA (MSSA) infections outside the central nervous system, 56.4% (n = 22) of respondents preferred cefazolin. Ceftriaxone/cefotaxime was used as definitive treatment for MSSA by 26.3% (n = 10). Prescribing penicillin for penicillin sensitive SA was divided with 51.3% (n = 20) choosing to use it. Most respondents chose to treat SA bacteremia (SAB) with no focus in immunocompetent children and neonates for 14 days, 89.7% (n = 35) and 92.3% (n = 36), respectively. Variability was observed in the practices of ordering abdominal ultrasounds and echocardiograms for SAB with no focus, and in the transition to oral antibiotics for MSSA bacteremia. Variability was also noted in treating osteoarticular infections with methicillin resistant SA bacteremia, with 56.4% (n = 22) choosing intravenous antibiotics until an appropriate clinical response is observed while others advised a minimum 7 (17.9%, n = 7) or 14 (12.8%, n = 5) day intravenous course. Conclusion: Our study highlights both areas of consistency and variability among Canadian PID physicians in managing serious SA infections in children, emphasizing the need for evidence-based paediatric guidelines and increased inclusion of children in clinical trials.
- 30 December 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 80 (4) , 715-722
Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis
Background: Shorter courses of antibiotic therapy are increasingly recommended to reduce antibiotic exposure. However, quantifying the real-world impact of duration of therapy is hindered by bias common in observational studies. We aimed to evaluate the harms and benefits of longer versus shorter duration of therapy in older adults. Methods: This was a population-based cohort study using administrative health data from Ontario, Canada. We included outpatients aged 66–110 years who received a prescription for amoxicillin, cephalexin, and/or ciprofloxacin. Prescriptions were categorized as short (3–7 days) or long (8–14 days) duration. The primary outcome was a composite of antibiotic-related harms, including adverse reactions, Clostridioides difficile infection, and antibiotic resistance. The secondary outcome was a composite of safety measures including repeat antibiotic prescriptions, hospital visits, and mortality. To reduce risk of bias, we used an instrumental variable analysis where the instrument was prescriber proportion of antibiotics that were long duration. Results: Among 117 682 eligible patients, there was no difference in the primary harms outcome for patients receiving longer versus shorter courses of antibiotics (adjusted odds ratio and 95% confidence interval [CI]): amoxicillin, 0.99 (.84–1.15); cephalexin, 1.11 (.90–1.38); ciprofloxacin, 0.94 (.74–1.20). Secondary safety outcomes were similar, with longer compared to shorter courses of antibiotic therapy (odds ratio and 95% CI): amoxicillin, 1.01 (.94–1.08); cephalexin, 1.06 (.97–1.17); ciprofloxacin, 0.99 (.85–1.15). Conclusions: In this instrumental variable analysis of community-dwelling older adults, longer antibiotic courses were not associated with an increased benefit or harm compared to shorter courses.
- 30 December 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 80 (4) , 715-722
Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis
Background: Shorter courses of antibiotic therapy are increasingly recommended to reduce antibiotic exposure. However, quantifying the real-world impact of duration of therapy is hindered by bias common in observational studies. We aimed to evaluate the harms and benefits of longer versus shorter duration of therapy in older adults. Methods: This was a population-based cohort study using administrative health data from Ontario, Canada. We included outpatients aged 66–110 years who received a prescription for amoxicillin, cephalexin, and/or ciprofloxacin. Prescriptions were categorized as short (3–7 days) or long (8–14 days) duration. The primary outcome was a composite of antibiotic-related harms, including adverse reactions, Clostridioides difficile infection, and antibiotic resistance. The secondary outcome was a composite of safety measures including repeat antibiotic prescriptions, hospital visits, and mortality. To reduce risk of bias, we used an instrumental variable analysis where the instrument was prescriber proportion of antibiotics that were long duration. Results: Among 117 682 eligible patients, there was no difference in the primary harms outcome for patients receiving longer versus shorter courses of antibiotics (adjusted odds ratio and 95% confidence interval [CI]): amoxicillin, 0.99 (.84–1.15); cephalexin, 1.11 (.90–1.38); ciprofloxacin, 0.94 (.74–1.20). Secondary safety outcomes were similar, with longer compared to shorter courses of antibiotic therapy (odds ratio and 95% CI): amoxicillin, 1.01 (.94–1.08); cephalexin, 1.06 (.97–1.17); ciprofloxacin, 0.99 (.85–1.15). Conclusions: In this instrumental variable analysis of community-dwelling older adults, longer antibiotic courses were not associated with an increased benefit or harm compared to shorter courses.
- Open Access
- 31 October 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (43) , E1678-E1679
Prise en charge conservatrice d’un hydropneumothorax chez une enfant de 4 ans atteinte de pneumonie
- 31 October 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (43) , E1678-E1679
Open AccessPrise en charge conservatrice d’un hydropneumothorax chez une enfant de 4 ans atteinte de pneumonie
- 1 April 2001
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 17 (2) , 81-88
Echocardiographic quantification of left ventricular asynergy in coronary artery disease with Fourier phase imaging
Background: Visual evaluation of wall motion is subjective and may be difficult in patients with impaired left ventricular function. Current algorithms used to analyze wall motion usually neglect...
- 1 April 2001
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 17 (2) , 81-88
Echocardiographic quantification of left ventricular asynergy in coronary artery disease with Fourier phase imaging
Background: Visual evaluation of wall motion is subjective and may be difficult in patients with impaired left ventricular function. Current algorithms used to analyze wall motion usually neglect...